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Summary
 Aim Patients with squamous cell carcinoma of the head and neck (HNSCC) aged less than 45 years are 
classed as young adults and in opinion of many authors compared to older (typical) patients ap-
pear more serious forms of the disease and often lack the classical risk factors associated with the 
illness. There is a need of an exact clinical analysis and a search for additional causative factors. 
The purpose of this study was to estimate the role of genetic factors in the aetiology of HNSCC in 
young adults.
Materials/Methods Studies carried out on 44 patients estimated: 1) the degree of chromosomal instability (bleomycin 
test), 2) the degree of spontaneous and induced DNA damage and potential of DNA repair (com-
et assay) and 3) polymorphisms of selected genes of carcinogens metabolism and DNA repair (gen-
otyping).
 Results The degree of chromosomal instability was a little lower in young adults group than in typical pa-
tients group, but the differences were not statistically signiﬁ cant. The level of spontaneous and in-
duced DNA damage and it’s removal by DNA repair were comparable in the groups of young adults 
and typical patients. Concerning genotyping we showed in the group of young adults a statistically 
signiﬁ cant more often co-occurrence of GSTM1(-) and NAT2*4/6A genotypes (p<0.05) and statis-
tically signiﬁ cant lower frequency of allele CYP1A1*4 (p<0.02). Differences between the other risk 
genotypes and alleles (CYP1A1*4/*4, NAT2*4/*6A, XPD35931AA, NAT2*4) were not shown to be 
statistically signiﬁ cant.
 Conclusions The studies parameter revealed only a weak prevelancve of genetic predisposition to HNSCC in 
young adults.
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BACKGROUND
Squamous cell carcinoma of the head and neck (HNSCC) 
is a malignant tumour arising most frequently in non-kerat-
inised epithelial tissue of the upper part of the respiratory 
or gastrointestinal tracts. The disease accounts for 6% of 
all cancers and about 90% of all malignant tumours of the 
head and neck. In this category the most common tumours 
are of the larynx (about 70%) and the tongue and palatine 
tonsil (about 25%). These tumours are closely associated 
with well known causative factors such as tobacco smoking 
and alcohol abuse and develop most commonly in men in 
the sixth or seventh decade of life. However, it is possible 
to deﬁ ne three groups of patients among whom these can-
cers develop signiﬁ cantly rarer - they are: people who nei-
ther drink nor smoke, women and young adults.
Young adults are patients aged younger than 45 (or 40) 
years (this age limit is not exactly ﬁ xed, but the majority 
of authors set the limit at 40 or 45 years). This idea is used 
widely in medicine, not only in cancers of the head and 
neck but also in other neoplastic diseases (e.g. lung can-
cer) and in non-neoplastic diseases (e.g. heart disease). In 
head and neck cancer patients this small group (about 5–
10%) has attracted the attention of researchers a long time 
ago [1,2], by the reason of observed differences in causes 
and results of treatment of these neoplasms in comparison 
with typical (older) patients. Many authors have noted worse 
results of treatment in young adults group (worse 3-years 
and 5-years survivals, more quickly spreading to the lymph 
nodes and more often local recurrences) [3–6], which may 
be the effects of more aggressive character of the tumour 
[4] or more advanced stage at the time of diagnosis (later 
appearance at doctor and later beginning the treatment) 
[5]. However some papers provided quite different ﬁ nd-
ings including similar or even better outcome of treatment 
of HNSCC in young adults than in typical patients [7–13]. 
A number of studies have also shown a lack of typical can-
cer causing factors (tobacco smoking and alcohol abuse) 
in young adults [10,12,14–17], that resulted in search for 
additional causative factors. The later ﬁ ndings turned an 
attention for an increased genetic predisposition [18-25], 
weakened immune system [26] and narcotic abuse (mari-
juana and hashish) [27]. Some authors, however, link ear-
lier incidence of HNSCC with very high exposure to ciga-
rettes and alcohol [4].
AIM
This study was aiming for the genetic conditions associat-
ed with squamous cell carcinoma of the head and neck in 
young adults. Using various tests, the study compares the 
level of chromosomal instability, the level of DNA damage 
(either spontaneous or induced), DNA repair capacity and 
a distribution of risk genotypes and alleles associated with 
carcinogens metabolism and DNA repair in groups of young 
and typical patients.
MATERIALS AND METHODS
The study group consisted of 44 patients aged below 
45 years treated in the Department of Otolaryngology and 
Laryngological Oncology of Karol Marcinkowski University 
of Medical Sciences in Poznań during the period 2001–2003. 
The study material were leukocytes isolated from blood tak-
en from patients before surgery. Patients were qualiﬁ ed for 
testing if they had not previously received chemotherapy or 
radiotherapy. Three analytical techniques were used.
1.  Bleomycin test was used to determine chromosomal insta-
bility by induction chromosomal aberrations by bleomy-
cin in cells cultured in vitro [28]. For every patient 2 cul-
tures were maintained (12 cases, 72 hours, 37°C). After 
67 hours bleomycin (Bleocin – Nippon Kayaku Co, Ltd.; 
30 mU/ml of culture) was applied and after 71 hours col-
chicine was added (to stop the cell cycle at metaphase). 
Cultures were harvested using typical cytogenetic meth-
ods; the material was collected on slides and stained in a 
5% solution of Giemsa’s stain and analysed by light micro-
scope. For each patient 50 metaphases were estimated for 
two parameters: b/c ratio (breaks per cell – a number of 
breaks of chromosomes in a cell) and the percentage of 
damaged cells. The scale of values for b/c were described 
by Hsu and co-workers as follows: b/c value <0.8 repre-
sents stable chromosomes, b/c >0.8 and <1.0 shows un-
stable chromosomes and b/c >1.0 shows increased chro-
mosomal instability.
2.  The comet assay allows to determine the spontaneous 
and induced DNA damage and DNA repair capacity [29]. 
Lymphocytes were isolated from circulatory blood (5 ml 
from 20 donors) and from these: (A) part was used for 
determining spontaneous DNA damage, (B) part was ex-
posed to the model mutagen bleomycin (induced damage) 
and (C) part was exposed to bleomycin and then incubat-
ed for 30 minutes at 37°C to determine DNA repair. The 
lymphocytes were then embedded in agarose gel, lysed, 
denaturated, electrophoresed, neutralised, stained (DAPI) 
and analysed by ﬂ uorescent microscopy. The length of 100 
comets was determined for each sample.
3.  Genotyping. We analysed the polymorphisms of selected 
genes involved in the metabolism of carcinogens and DNA 
repair (24 patients) [30]. Polymorphic variants were de-
termined for the following genes: CYP1A1, NAT2, GSTM1 
and XPD and the frequency of these genotypes and alle-
les was calculated. We estimated the frequencies of these 
genotypes and alleles in young adults group, which had 
appeared signiﬁ cantly more often in pre-analysed large 
group of almost 300 typical patients with laryngeal can-
cer than in the healthy people group (risk genotypes and 
alleles). DNA was isolated from circulatory blood by the 
phenol method and fragments to be tested were ampli-
ﬁ ed by the PCR technique. In the case of analysis of the 
polymorphism of genes connected with the presence of 
deletion variants (GSTM1) the PCR products were identi-
ﬁ ed by agarose gel electrophoresis. In the case of analysis 
of the polymorphism of remaining genes PCR products 
were hydrolyzed by restriction enzymes (RFLP technique) 
followed by agarose gel electrophoresis.
The control group in all these tests consisted of typical pa-
tients treated in the same period.
RESULTS
The results are shown in Figures 1–6.
A)  Bleomycin Test. In young adults group the level of chro-
mosome damage was lower than in the typical patients 
group (ratio b/c – median value 0.52 vs 0.96 and per-
centage of damaged cells – median value 36% vs 44%), 
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but the differences were not statistically signiﬁ cant (U 
Mann Whitney test) (Figures 1 and 2).
B)  Comet Assay. The levels of spontaneous and bleomy-
cin-induced DNA damages and DNA repair potential 
were similar in both young and typical patients groups 
(Figures 3–5). Median values for spontaneous dam-
ages (sample 0) for young adults and typical patients 
were 62.00 and 64.05, for bleomycin-induced damag-
es (sample BLM) were 75.55 and 73.33, and the me-
dian values for differences between induced damages 
and induced damages with DNA repair (sample BLM 
– sample BLM-N) were 0.69 and 0.85. In no instance 
there was a statistically signiﬁ cant difference (U Mann 
Whitney test).
Figure 1. Bleomycin test. Induced chromosomal damage – b/c ratio. Figure 4. Comet Assay. Induced DNA damage (sample BLM).
Figure 2. Bleomycin test. Induced chromosomal damage – percentage 
of damaged cells.
Figure 3. Comet Assay. Spontaneous DNA damage (sample 0).
Figure 5. Comet Assay. Induced DNA damage followed by DNA repair 
(sample BLM-N).
Figure 6. Genotyping. Frequency of risk genotypes and alleles.
Rep Pract Oncol Radiother, 2005; 10(1): 17-21 Gawęcki W et al – Head and neck carcinoma in young adults
19
C)  Genotyping. A distribution of risk genotypes and alle-
les among young adults was slightly different than those 
among typical patients (Figure 6). In young adults there 
was a statistically signiﬁ cant more often co-occurrence of 
GSTM1(-) and NAT2*4/6A genotypes (p<0.05) and sta-
tistically signiﬁ cant lower frequency of allele CYP1A1*4 
(p<0.02) than in typical patients. The differences between 
the remaining genotypes and alleles (CYP1A1*4/*4, 
NAT2*4/*6A, XPD35931AA, NAT2*4) were not found 
to be statistically signiﬁ cant.
CONCLUSIONS
Genetic factors may have a role in the etiopathogenesis of 
squamous cell carcinoma of the head and neck in young 
adults. Predisposition to suffering from this disease may be 
linked to risk genotypes and alleles involved in the metab-
olism of carcinogens.
DISCUSSION
The character of squamous cell carcinoma of the head 
and neck among young adults is a topic of some contro-
versies. Typical and non-typical factors in etiopathogene-
sis and differences in clinical progress, as compared with 
those for typical (older) patients, are discussed in many arti-
cles [4,5,10,12,14,20–22,24,26,27]. The questions of wheth-
er to consider young adults as a distinct group and where 
to set the upper age limit (45, 40 or 35 years) remain open. 
Among authors who conﬁ rmed the worse results of treat-
ment of HNSCC in young adults there is no agreement of 
the reasons of such situation. It may be the effect of more 
advanced stage of illness at the time of diagnosis or more 
aggressive character of the tumour connected with differ-
ent etiological factors.
In order to clarify this problem genetic factors should be 
taken into account.
To date, a few papers has been published about the role 
of genetic factor in the etiopathogenesis of squamous cell 
carcinoma of the head and neck in young adults [18–25]. 
In 1989 Schantz et al. [22] used the bleomycin test in a 
group of young people (age <40 years) with HNSCC and 
showed an increased level of induced chromosomal dam-
age connected with a high degree of chromosomal insta-
bility (b/c ratio 0.96). The control group of young healthy 
subjects showed a b/c ratio of 0.62 and young patients with 
nonsquamous cell carcinoma of the head and neck showed 
a b/c ratio of 0.50. Papworth et al. [20] conﬁ rmed the in-
creased susceptibility of young adults to exogenous factors 
showing high levels of chromosomal aberrations and mi-
cronuclei formation caused by X-rays. Similarly, Llewellyn 
et al. [31] reviewed 46 publications and indicated that ge-
netic instability may be one of the causes of squamous cell 
cancers of the head and neck in young adults. During the 
course of our study we did not ﬁ nd chromosomal instability 
to be a cause of HNSCC in young adults and found even a 
little lower level of chromosomal damage in group of young 
adults than in group of typical patients. The reason for dif-
ferences between earlier and our results is not clear and is 
perhaps related to 3 facts. The most important is the differ-
ence in control group – Schantz compared young adults with 
HNSCC with young healthy individuals and with young pa-
tients with nonsquamous cell cancers of the head and neck, 
but we compared young adults with typical patients. The re-
sults showed by Schantz doesn’t answer the question about 
the differences in etiology of the HNSCC in young adults 
and typical patients, because higher levels of chromosome 
instability in typical patients group than in healthy controls 
were shown in many papers. The another reason of these 
differences may be the small numbers included in the an-
alysed groups (Schantz – study included 20 subjects, our 
group – 12 subjects) or the variation in age limits (Schantz 
– 40 years, our group – 45 years), but also in our group pa-
tients aged less than 40 years showed the level of chromo-
somal damage no higher than in the control group.
Comet assay and analysis of polymorphisms of selected genes 
of carcinogens metabolism and DNA repair have not been 
carried out before.
We found no differences between the results of comet as-
say in our tested groups suggesting that the sensitivity of 
DNA to carcinogens does not account for early occurrence 
of these neoplasms.
Several studies have tested the effects of genetic changes 
in genes involved in regulation of the cell cycle (p53, p21, 
Rb, MDM2) [18,19,21,23,25], but the results of these stud-
ies were not equivocal. Wang et al. [24] showed that young 
patients with HNSCC more commonly than typical patients 
display microsatellite instability but there is no difference in 
genes connected with DNA repair (hMLH1 and hMSH2). Jin 
et al. [19] searched a loss of heterozygosity in the neoplastic 
cells of the oral cavity and healthy epithelium and showed 
similar results in young adults and typical patients.
Our analysis of the frequency of risk genotypes and alle-
les in young adults is very preliminary, because of the small 
number of genes analysed and the small largeness of groups. 
However analysed genes were selected such that they repre-
sent the processes of activation of carcinogens (CYP 1A1), 
their detoxication (GSTM1 and NAT2) and DNA repair 
(XPD). The results point to decrease of the correct proc-
ess of detoxication connected with increase in so called 
risk genotypes.
The answer to the question of whether genetic factors play 
a role in the etiopathogenesis of HNSCC in young adults 
is not equivocal. The role of chromosomal instability re-
mains unsolved. The level of spontaneous and induced DNA 
damage and DNA repair potential is comparable between 
groups of young adults and typical patients. The results ob-
tained in our study show at the possible role of risk geno-
types and alleles connected with the metabolism of carcin-
ogens. The deﬁ nition of the role of genetic factors in the 
etiopathogenesis of squamous cell cancer of the head and 
neck will require further studies on larger groups of pa-
tients. In this context our work is getting a character of pi-
lot study. There remains the question about the role of ex-
ogenous factors in the etiopathogenesis of HNSCC in young 
adults. In the patients we studied, the mean number of cig-
arettes smoked daily was 20.91 while in typical patients it 
was 18.65 which suggests an important role of this factor. 
In the next stage of our work we plan to continue genetic 
testing in a larger group of patients and to analyse cases of 
squamous cell carcinoma of the head and neck in young 
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people retrospectively with the aim of identifying possible 
etiological factors.
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